ASEP Medical Holdings Inc. (CSE:ASEP)
Canada · Delayed Price · Currency is CAD 0.5000
0.00 (0.00%)
May 5, 2025, 3:56 PM EDT
ASEP Medical Holdings Company Description
ASEP Medical Holdings Inc., together with its subsidiaries, focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis.
It offers peptide technology for therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and coatings for medical devices.
The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021.
ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.
ASEP Medical Holdings Inc.
| Country | Canada |
| Founded | 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Robert E. Hancock |
Contact Details
Address: 730 View Street Victoria, British Columbia V8W 3Y7 Canada | |
| Phone | 778 600 0509 |
| Website | asepmedical.com |
Stock Details
| Ticker Symbol | ASEP |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA04368A1057 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Robert E. W. Hancock FRSC, OC, Ph.D. | Founder, Chief Executive Officer and Executive Chairman |
| Jacqueline M. Tucker F.C.A., FCPA | Chief Financial Officer |
| Timothy William Murphy | Chief Operating Officer, Corporate Secretary and Director |
| Dr. Evan Haney | Chief Scientific Officer |
| Dr. Fadia Saad M.B.A., Ph.D. | Chief Business Development Officer |